Rock Springs Capital Management LP Heron Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $490,800 - $641,700	-30,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $5.42 Million - $8.39 Million	-320,000 Reduced 91.43%	30,000 $558,000
Q1 2019 May 15, 2019	SELL	$23.15 - $28.34 $4.05 Million - $4.96 Million	-175,000 Reduced 33.33%	350,000 $8.55 Million
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $1.29 Million - $2.06 Million	49,000 Added 10.29%	525,000 $20.4 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $4.17 Million - $6.51 Million	226,000 Added 90.4%	476,000 $13.1 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $3.7 Million - $4.71 Million	250,000	250,000 $4.53 Million

176

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $210M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.